Kymera Therapeutics Inc. (KYMR)
undefined
undefined%
At close: undefined
42.13
0.36%
After-hours Dec 13, 2024, 04:15 PM EST

Kymera Therapeutics Inc. Forcast

Stock Price Forecast

The 16 analysts with 12-month price forecasts for KYMR stock have an median target of 56, with a low estimate of 36 and a high estimate of 74. The median target predicts an increase of 33.40% from the current stock price of 41.98.

Analyst Consensus: Buy
Target Low Average Median High
Price $36 $55.6 $56 $74
Change -14.24% 32.44% 33.40% 76.27%

AI Analyst Report

Truist Securities maintains a Buy rating on Kymera... Unlock content with Pro Subscription

Updated Nov 01, 2024

Rating Jun 24Jul 24Aug 24Sep 24Nov 24Dec 24
Strong Buy 000000
Buy 211232
Hold 012011
Sell 000000
Strong Sell 000000
Total 2 2 3 2 4 3

Financial Forecast this Year

Revenue This Year
58.29M
from 78.59M
Increased by -25.8%
Revenue Next Year
67.39M
from 58.29M
Increased by 15.6%
EPS This Year
-2.93
from -2.52
Increased by -16.3%
EPS Next Year
-3.53
from -2.93
Increased by -20.5%